{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:08:21Z","timestamp":1793725701048,"version":"4.6.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>A 62-year-old Chinese woman presented to the hospital for help with generalized pustular psoriasis (GPP) and acrodermatitis continua of Hallopeau (ACH). While conventional treatments failed to achieve significant improvement, the patient received two doses of spesolimab, and the effect was remarkable. No adverse reactions were observed in the follow-up period.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1563553","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:28:30Z","timestamp":1747286910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights"],"prefix":"10.3389","volume":"16","author":[{"given":"Xin-Yi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-chu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-021-00655-y","article-title":"Pathophysiology of generalized pustular psoriasis","volume":"23","author":"Marrakchi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc1811317","article-title":"Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis","volume":"380","author":"Bachelez","year":"2019","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000346572","article-title":"Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis","volume":"226","author":"Abbas","year":"2013","journal-title":"Dermatology"},{"key":"B4","article-title":"Pustular psoriasis: pathophysiology and current treatment perspectives","volume":"6","author":"Benjegerdes","year":"2016","journal-title":"Psoriasis (Auckl)"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-4632.2011.04993.x","article-title":"Acrodermatitis continua of Hallopeau: evolution of treatment options","volume":"50","author":"Sehgal","year":"2011","journal-title":"Int J Dermatol"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-022-00830-x","article-title":"Commentary on a clinical trial of spesolimab, a humanized anti-interleukin-36 receptor monoclonal antibody, in generalized pustular psoriasis","volume":"12","author":"Shao","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-021-00612-x","article-title":"Pustular psoriasis: A narrative review of recent developments in pathophysiology and therapeutic options","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1080\/1744666X.2019.1648209","article-title":"An update on generalized pustular psoriasis","volume":"15","author":"Gooderham","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/ijmm.2021.4951","article-title":"An update on genetic basis of generalized pustular psoriasis (Review)","volume":"47","author":"Zhou","year":"2021","journal-title":"Int J Mol Med"},{"key":"B11","doi-asserted-by":"crossref","first-page":"adv00034","DOI":"10.2340\/00015555-3388","article-title":"Pustular psoriasis: the dawn of a new era","volume":"100","author":"Bachelez","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.038","article-title":"Clinical and genetic differences between pustular psoriasis subtypes","volume":"143","author":"Twelves","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043666","article-title":"Study protocol of the global Effisayil 1 multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare","volume":"11","author":"Choon","year":"2021","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2022.2103536","article-title":"Safety and tolerability of spesolimab in patients with ulcerative colitis","volume":"22","author":"Ferrante","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/vaccines11081298","article-title":"Pustular eruption following COVID-19 vaccination: A narrative case-based review","volume":"11","author":"Karampinis","year":"2023","journal-title":"Vaccines (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1563553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:28:32Z","timestamp":1747286912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1563553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":15,"alternative-id":["10.3389\/fimmu.2025.1563553"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1563553","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1563553"}}